ASML vs PFE · P/E 57, $665.37B cap vs P/E 20, rev $62.58B
ASML Holding NV ADR (ASML) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
ASML does not have a complete income-statement cache yet.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ASML and PFE stock pages for the full models.
Not investment advice.